128 related articles for article (PubMed ID: 11205742)
1. Morphologic conversion of a neuroblastoma-derived cell line by E6-mediated p53 degradation.
Gaitonde SV; Qi W; Falsey RR; Sidell N; Martinez JD
Cell Growth Differ; 2001 Jan; 12(1):19-27. PubMed ID: 11205742
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
3. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
Chen QM; Merrett JB; Dilley T; Purdom S
Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
[TBL] [Abstract][Full Text] [Related]
4. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
5. HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways.
Kim HJ; Guo W; Park NH
Oncol Rep; 2000; 7(4):707-12. PubMed ID: 10854530
[TBL] [Abstract][Full Text] [Related]
6. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
9. HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells.
Duerksen-Hughes PJ; Yang J; Schwartz SB
Virology; 1999 Nov; 264(1):55-65. PubMed ID: 10544129
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis.
Seewaldt VL; Mrózek K; Dietze EC; Parker M; Caldwell LE
Cancer Res; 2001 Jan; 61(2):616-24. PubMed ID: 11212259
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
[TBL] [Abstract][Full Text] [Related]
12. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
14. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells.
Zheng YF; Zhang JR
Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702
[TBL] [Abstract][Full Text] [Related]
15. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Hampson L; Kitchener HC; Hampson IN
Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
[TBL] [Abstract][Full Text] [Related]
16. Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids.
Isaacs JS; Chen P; Garza A; Hansen MF; Barrett JC; Weissman BE
Oncogene; 1997 Apr; 14(14):1669-78. PubMed ID: 9135068
[TBL] [Abstract][Full Text] [Related]
17. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R
Oncogene; 2009 Apr; 28(17):1881-91. PubMed ID: 19330020
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation.
Sherman L; Jackman A; Itzhaki H; Stöppler MC; Koval D; Schlegel R
Virology; 1997 Oct; 237(2):296-306. PubMed ID: 9356341
[TBL] [Abstract][Full Text] [Related]
19. Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.
Rogers DA; Schor NF
Exp Cell Res; 2013 Mar; 319(5):660-9. PubMed ID: 23333500
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi.
Zheng YF; Rao ZG; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):496-8. PubMed ID: 12297466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
